000			02317 a2200625 4500
005			20250514160623.0
264		0	_c20040323
008			200403s 0 0 eng d
022			_a1042-8194
024	7		_a10.3109/10428190309178781 _2doi
040			_aNLM _beng _cNLM
100	1		_aUckun, Fatih M
245	0	0	_aThe anti-leukemic Bruton's tyrosine kinase inhibitor alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl) propenamide (LFM-A13) prevents fatal thromboembolism. _h[electronic resource]
260			_bLeukemia & lymphoma _cSep 2003
300			_a1569-77 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdenosine Diphosphate _xpharmacology
650	0	4	_aAgammaglobulinaemia Tyrosine Kinase
650	0	4	_aAmides _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAspirin _xpharmacology
650	0	4	_aBleeding Time
650	0	4	_aCatalytic Domain _xdrug effects
650	0	4	_aCollagen _xantagonists & inhibitors
650	0	4	_aDrug Design
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aFibrinolytic Agents _xpharmacology
650	0	4	_aHumans
650	0	4	_aJanus Kinase 3
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred ICR
650	0	4	_aNitriles _xpharmacology
650	0	4	_aPeptide Fragments _xpharmacology
650	0	4	_aPlatelet Activation _xdrug effects
650	0	4	_aPlatelet Aggregation _xdrug effects
650	0	4	_aPlatelet Aggregation Inhibitors _xpharmacology
650	0	4	_aPlatelet Membrane Glycoproteins _xdrug effects
650	0	4	_aProtein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aPulmonary Embolism _xchemically induced
650	0	4	_aQuinazolines _xpharmacology
650	0	4	_aReceptors, Collagen _xdrug effects
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aThrombin _xpharmacology
650	0	4	_aThromboembolism _xchemically induced
650	0	4	_aThromboplastin _xtoxicity
700	1		_aVassilev, Alexei
700	1		_aBartell, Steve
700	1		_aZheng, Yaguo
700	1		_aMahajan, Sandeep
700	1		_aTibbles, Heather E
773	0		_tLeukemia & lymphoma _gvol. 44 _gno. 9 _gp. 1569-77
856	4	0	_uhttps://doi.org/10.3109/10428190309178781 _zAvailable from publisher's website
999			_c14308416 _d14308416